Medicine and Dentistry
Cerebral Hemorrhage
100%
Bleeding
54%
Blood Clot Lysis
41%
Alteplase
40%
Evacuation
32%
Minimally Invasive Surgery
32%
Clinical Trial
25%
Hematoma
19%
COVID-19
18%
Cavernous Hemangioma
18%
Infection
18%
Modified Rankin Scale
17%
Placebo
16%
Randomized Controlled Trial
14%
Odds Ratio
13%
Outpatient
12%
Convalescence
12%
Quantitative Susceptibility Mapping
12%
Computer Assisted Tomography
12%
Biological Marker
11%
Hypothermia
11%
Adverse Event
10%
Aneurysm Surgery
9%
Apoplexy
8%
Cardiovascular System
8%
Congenital Malformation
8%
Brain Artery Aneurysm
8%
Medical Care
6%
Functional Status
6%
Surgeon
6%
Subarachnoid Hemorrhage
6%
Systolic Blood Pressure
5%
Thrombolytic Drug
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Systematic Review
5%
Logistic Regression Analysis
5%
Low Drug Dose
5%
Keyphrases
Intraventricular Hemorrhage
44%
Intracerebral Hemorrhage
22%
Clot Lysis
18%
Symptomatic Hemorrhage
18%
Convalescent Plasma
17%
Trial Readiness
17%
Spontaneous Intracerebral Hemorrhage
15%
Modified Rankin Scale
15%
COVID-19
14%
Alteplase
12%
External Ventricular Drain
11%
Thrombolysis
11%
Evacuation
11%
MISTIE
11%
Minimally Invasive Surgery
10%
Placebo-controlled
9%
Clinical Trials
9%
Phase II Trial
9%
Bleeding
8%
Hemorrhage Volume
8%
Adjusted Odds Ratio
8%
Quantitative Susceptibility Mapping
8%
Cavernous Malformation
8%
Cavernous Angioma
8%
Cerebral Aneurysm Surgery
8%
Clinical Outcomes
8%
Adverse Events
7%
Transfusion
6%
Survivors
6%
Confidence Interval
6%
Patient Characteristics
5%
Rebleeding
5%
COVID-19 Convalescent Plasma
5%
Catheter
5%
Placebo
5%
Inflammation
5%
Intraventricular
5%
Severe Disabilities
5%
Multisite Trials
5%
Odds Ratio
5%
